10/14/2019

IVI Discusses Expanding Support for Global Collaboration on Vaccine R&D and Delivery with Top Foreign Diplomats in Seoul

IVI State Forum 2019 was attended by 8th UN Secretary-General Ban Ki-moon, as well as 30 distinguished guests, including 17 ambassadors and top diplomats in Seoul, and senior Korean government officials.   The IVI State Forum 2019 was attended by ambassadors and senior diplomats from […]
10/17/2019

IVI and the USask’s VIDO-InterVac Exchange MOU to Advance Vaccine Research

Professor Peter Stoicheff, President of USask (left), and Dr. Jerome Kim, DG of IVI, sign an MOU at IVI’s headquarters   October 16, 2019, SEOUL, Korea — IVI and the University of Saskatchewan’s (USask) VIDO-InterVac, a global leader in infectious disease research and vaccine development, […]
10/29/2019

IVI Awarded $4.5 Million Grant to Increase Accessibility of Oral Cholera Vaccine

October 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to simplify the current oral cholera vaccine (OCV) and further increase its accessibility. To date, the Gates Foundation has […]
10/31/2019

8th UN Secretary-General Ban Ki-moon delivers congratulatory remarks during IVI State Forum 2019

IVI hosted a State Forum at their headquarters in Seoul on Friday, October 11, showcasing the impact of international cooperation in vaccine research and development (R&D), and delivery in low- and middle-income countries. The Forum was attended by ambassadors and senior diplomats from 17 countries, […]